NCT05238831 2024-01-23SMMART Adaptive Clinical Treatment (ACT) TrialOHSU Knight Cancer InstitutePhase EARLY_PHASE1 Withdrawn
NCT00499291 2023-05-25Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid TumorsEastern Cooperative Oncology GroupPhase NA Withdrawn
NCT04464967 2021-05-12Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR CancersNKGen Biotech, Inc.Phase 1/2 Withdrawn
NCT01386502 2017-07-02CT-011 and p53 Genetic Vaccine for Advanced Solid TumorsNational Institutes of Health Clinical Center (CC)Phase 1 Withdrawn
NCT00378781 2012-02-24Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related InfectionM.D. Anderson Cancer CenterPhase NA Withdrawn